SS Innovations International, Inc. reported significant financial performance improvements in its latest 10-Q filing for the quarter ending March 31, 2026. The company generated total revenues of $11.1 million, a substantial increase of 117% compared to $5.1 million in the same period last year. This growth was primarily driven by a rise in system sales, which reached $9.6 million, up from $4.5 million in the previous year. The gross profit for the quarter was $5.3 million, compared to $1.1 million in the prior year, reflecting a gross margin improvement as the company continues to scale its operations.
The company’s net loss for the quarter was $3.6 million, a reduction from a loss of $5.7 million in the same quarter of 2025. This decrease in net loss was attributed to higher gross profits and a slight reduction in research and development expenses, which totaled $995,440, down from $1 million in the previous year. However, selling, general, and administrative expenses increased to $4.5 million from $3.4 million, driven by higher legal and underwriting fees associated with business events and operational expansion.
In terms of strategic developments, SS Innovations completed a private placement of common stock in March 2026, raising net proceeds of approximately $18.4 million. This capital will be utilized for working capital and to support the company’s growth initiatives, particularly in India and other global markets, as well as preparations for entry into the U.S. and European Union markets. The company also reported an increase in its employee headcount, reflecting its ongoing expansion efforts.
Operationally, SS Innovations sold 18 SSi Mantra surgical robotic systems during the quarter, with three systems installed on a pay-per-use basis. The company’s revenue from India accounted for 99% of total revenue, highlighting its strong market presence in the region. The company’s total assets increased to $90.5 million as of March 31, 2026, up from $74.2 million at the end of 2025, primarily due to increased cash reserves and investments in inventory and receivables.
Looking ahead, SS Innovations acknowledges the challenges of maintaining operational cash flows and the need for additional funding to support its growth plans. The management is optimistic about the potential for future revenue generation as awareness of robotic surgery increases and as the company continues to seek regulatory approvals for its products in various markets. However, the company also cautions that its ability to sustain operations and achieve profitability will depend on successful capital raising efforts and the execution of its strategic initiatives.
About SS Innovations International, Inc.
SS Innovations International, Inc. designs and markets affordable surgical robotic systems, primarily the SSi Mantra, to improve minimally invasive surgeries across diverse medical fields. Focused on underserved markets like India, it aims to expand globally through direct sales and distributor networks. The company emphasizes innovation, surgeon training, and remote telesurgery, offering cost-effective solutions that enhance patient outcomes and operational efficiency.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.